Informatie:
Fout:
ID
28997
Beschrijving
A phase IV, open, multicentre study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) given as a booster at 18-24 months of age to pre-term children who have received a three-dose primary immunization course with the same vaccine in study 217744/090.
Trefwoorden
Versies (1)
- 20-02-18 20-02-18 -
Houder van rechten
GlaxoSmithKline (GSK)
Geüploaded op
20 februari 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
DTPa-HBV-IPV/Hib vaccine (Infanrix-hexa) Study ID: 101518
Visit1 Informed consent and Demographics
- StudyEvent: ODM
Similar models
Visit1 Informed consent and Demographics
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Default Itemgroup
C0021430 (UMLS CUI-1)
C0011298 (UMLS CUI-3)
C0011298 (UMLS CUI-3)
Informed consent
Item
I certify that Informed Consent has been obtained prior to any study procedure.
boolean
C0021430 (UMLS CUI [1])
Centre number
Item
Centre number
integer
C2825181 (UMLS CUI [1,1])
C1300638 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,2])
date of birth
Item
date of birth
date
C0421451 (UMLS CUI [1])
CL Item
Male ([M])
CL Item
Female ([F])
CL Item
Black (1)
(Comment:en)
CL Item
Arabic/North African (2)
(Comment:en)
CL Item
White/Caucasian (3)
(Comment:en)
CL Item
East & South East Asian (4)
(Comment:en)
CL Item
South Asian (5)
(Comment:en)
CL Item
American Hispanic (6)
(Comment:en)
CL Item
Japanese (7)
(Comment:en)
CL Item
Other, please specify (8)
(Comment:en)